1 Result(s)

Article

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells

Redirection of T lymphocytes against tumor antigens can induce dramatic regression of advanced stage malignancy. The use of bispecific antibodies (BsAbs) that bind both the T-cell receptor (TCR) and a target a...

Katarzyna Urbanska, Rachel C Lynn, Caitlin Stashwick… in Journal of Translational Medicine (2014)